Abstract
The paper reports the inhibition kinetics of pig liver carboxylesterase (CE) by two food azo dyes, tartrazine (E 102) and green dye (E102-E132), using ethyl butyrate as substrate. Optimum pH and temperature for pig liver CE were found to be 8.0 and 45°C. The kinetics of CE-catalyzed hydrolysis of ethyl butyrate followed the Haldane model with an optimum substrate concentration of 30 mM. Km and Vmax values were found to be 9.44 mM and 504.62 M/min, respectively. Pig liver CE was significantly inhibited by tartrazine and green dye with IC50 values of 0.68 mM and 1.37 mM, respectively.
The kinetic analyses showed that the inhibition of CE activity by the tartrazine and green dye was uncompetitive type with KI values of 0.46 mM and 0.62 mM, respectively. From the experimental results, it was found that tartrazine is a more effective inhibitor due to lower KI and IC50 values.
Keywords: Carboxylesterase, food azo dyes, inhibition, kinetics, pig liver.
Graphical Abstract
Current Enzyme Inhibition
Title:Inhibitory effects of the Food Azo Dyes on Pig Liver Carboxylesterase Activity
Volume: 11 Issue: 2
Author(s): Wafaa Lemerini, Zoheir Arrar, Kajima Mulengi Joseph, Zoheir Dahmani, Wassila Drici, Naima Bouazzaoui and Djamel Bendiabdellah
Affiliation:
Keywords: Carboxylesterase, food azo dyes, inhibition, kinetics, pig liver.
Abstract: The paper reports the inhibition kinetics of pig liver carboxylesterase (CE) by two food azo dyes, tartrazine (E 102) and green dye (E102-E132), using ethyl butyrate as substrate. Optimum pH and temperature for pig liver CE were found to be 8.0 and 45°C. The kinetics of CE-catalyzed hydrolysis of ethyl butyrate followed the Haldane model with an optimum substrate concentration of 30 mM. Km and Vmax values were found to be 9.44 mM and 504.62 M/min, respectively. Pig liver CE was significantly inhibited by tartrazine and green dye with IC50 values of 0.68 mM and 1.37 mM, respectively.
The kinetic analyses showed that the inhibition of CE activity by the tartrazine and green dye was uncompetitive type with KI values of 0.46 mM and 0.62 mM, respectively. From the experimental results, it was found that tartrazine is a more effective inhibitor due to lower KI and IC50 values.
Export Options
About this article
Cite this article as:
Lemerini Wafaa, Arrar Zoheir, Joseph Mulengi Kajima, Dahmani Zoheir, Drici Wassila, Bouazzaoui Naima and Bendiabdellah Djamel, Inhibitory effects of the Food Azo Dyes on Pig Liver Carboxylesterase Activity, Current Enzyme Inhibition 2015; 11 (2) . https://dx.doi.org/10.2174/1573408011666150817200632
DOI https://dx.doi.org/10.2174/1573408011666150817200632 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiepileptic Drug Interactions - Principles and Clinical Implications
Current Neuropharmacology Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery
Current Pharmaceutical Design Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery DNAzyme Delivery Approaches in Biological Settings
Current Medicinal Chemistry Solar Exfoliated Graphene Oxide: A Platform for Electrochemical Sensing of Epinephrine
Current Analytical Chemistry Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors
Current Medicinal Chemistry Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Alopecia Areata
Recent Patents on Inflammation & Allergy Drug Discovery Herbal Nanoformulations for Asthma Treatment
Current Pharmaceutical Design Gene-Gene Interactions in a Context of Individual Variability in Antipsychotic Drug Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Cow’s Milk Allergenicity
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design The Medicinal Chemistry of Peptides
Current Medicinal Chemistry The Role of Dietary Fats in Hypertension, Obesity and Insulin Resistance: A Comparative Study of Animals and Humans in Fetal and Adult Life
Current Nutrition & Food Science Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets Recent Updates on the Systemic and Local Safety of Intranasal Steroids
Current Drug Metabolism Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Natural Products Triggering Biological Targets- A Review of the Anti-Inflammatory Phytochemicals Targeting the Arachidonic Acid Pathway in Allergy Asthma and Rheumatoid Arthritis
Current Drug Targets miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis
Current Pharmaceutical Design